PHC-12-2015
PHC-12-2015
12 projects · €39,664,336 total EU contribution (project-level) · 13 participating organizations · 8 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€39,664,336
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (4)
- Spain (2)
- IE (2)
- France (1)
- IL (1)
- Netherlands (1)
- PL (1)
- SE (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- BIOVICA1 projects · SE
- Oncovision1 projects · ES
- ALPHASIP1 projects · ES
- LIGHTPOINT1 projects · UK
- MEMED1 projects · IL
- MENSIA1 projects · FR
- NEMO HEALTHCARE BV1 projects · NL
- OM1 projects · IE
- P1VITAL1 projects · UK
- P1VITAL PRODUCTS LIMITED1 projects · UK
- PERSPECTUM LTD1 projects · UK
- PMD Device Solutions Limited1 projects · IE
Projects
Page 1 of 2
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Non-invasive rapid assessment of chronic liver disease using Magnetic Resonance Imaging with LiverMultiScan RADIcAL · 719445 | H2020 | €3,460,487 | €3,460,487 | Details |
Personalized medical device for the diagnosis and treatment of ADHD based on EEG biomarkers and Neurofeedback Training NEWROFEED · 684809 | H2020 | €3,600,633 | €3,600,633 | Details |
PNEUMOSIP PNEUMOSIP · 685052 | H2020 | €3,389,913 | €3,389,913 | Details |
OncoMasTR - Novel Prognostic Assay for Early Stage Breast Cancer OncoMasTR · 698630 | H2020 | €2,751,250 | €2,751,250 | Details |
Safe and accurate fetal monitoring FETAL MONITORING · 719500 | H2020 | €4,054,000 | €4,054,000 | Details |
Clinical validation of the DiviTum assay in two high profile clinical studies in Europe BIOVALID · 684862 | H2020 | €682,506 | €682,506 | Details |
Preventing Respiratory Events through Proactive Assessment of Respiratory Effort PREPARE · 711269 | H2020 | €4,265,610 | €4,265,610 | Details |
Clinical performance validation of a novel biomarker for quantitative imaging of coronary artery disease. MPIPETrace · 711083 | H2020 | €3,687,250 | €3,687,250 | Details |
A new brain-dedicated Positron Emission Tomography (PET) system to identify β-amyloid biomarker for the early diagnosis of Alzheimer’s disease and other causes of cognitive decline CAREMIBRAIN · 711323 | H2020 | €4,393,596 | €4,393,596 | Details |
Clinical validation of host biomarker signature for distinguishing bacterial versus viral lower respiratory tract infections (LRTI) in adults at the point-of-need Respiratory-ImmunoDx · 684589 | H2020 | €2,935,000 | €2,935,000 | Details |